Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
EMA OKs Sublingual Formulation for Opioid Dependence
The European Medicines Agency has recommended granting marketing authorization for a new hybrid formulation of buprenorphine as a substitution treatment of opioid drug dependence. Buprenorphine Neuraxpharm is available as multiple-strength sublingual films. The Committee for Medicinal Products for Human Use…
English